1 outlets · filed 10 November 2026
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
What the coverage shows
All five outlets center on the FDA warning that GLP-1 drugs may be linked to a rare eye condition that can cause serious vision loss or blindness. BBC News and The Guardian US are the only ones to foreground labeling changes, with BBC saying makers were ordered to add warnings and The Guardian saying the FDA is requiring all GLP-1s to include the risk on warning labels. Ars Technica uniquely stresses that the risk appears small and the data are mixed, while CNBC frames it as evidence of a potential increased risk.
Written by Crossfiled from the 1 headlines and extracts below, not from the articles themselves. It describes how the outlets framed this, not what happened. Open any headline for a summary of that article.
How it broke
Get the 5 stories every outlet is covering, every morning. Free.
One email a day. Unsubscribe in one click. We host no journalism and never sell your address.
More on Health
- Indonesia factory fire kills three, 36 missing 3 outlets
- Princess of Wales opens up about cancer 2 outlets
- Princess Kate reflects on healing in new documentary: "Cancer does change you" 2 outlets
- Violence breaks out in Mexico after capture of drug kingpin wanted by FBI 2 outlets
